| 101 |
26357605 | Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral Response. | 2013 Sep |
6 |
| 102 |
30534284 | Sick sinus syndrome induced by interferon and ribavirin therapy in a patient with chronic hepatitis C. | 2013 Dec |
2 |
| 103 |
21293098 | Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy. | 2012 |
1 |
| 104 |
21734353 | Amino acid substitution in HCV core/NS5A region and genetic variation near IL28B gene affect treatment efficacy to interferon plus ribavirin combination therapy. | 2012 |
1 |
| 105 |
21898478 | Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response. | 2012 Jan |
1 |
| 106 |
21932410 | Treatment of chronic hepatitis C genotype 1 patients at an academic center in Europe involved in prospective, controlled trials: is there a selection bias? | 2012 Jan |
1 |
| 107 |
22038554 | Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells. | 2012 Feb |
1 |
| 108 |
22212579 | The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C. | 2012 Feb |
1 |
| 109 |
22300892 | Continuous interferon-α2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients. | 2012 |
1 |
| 110 |
22328925 | Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients. | 2012 |
1 |
| 111 |
22331604 | Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response. | 2012 Aug |
1 |
| 112 |
22351942 | Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline. | 2012 Apr 1 |
1 |
| 113 |
22357660 | Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8. | 2012 Apr 1 |
1 |
| 114 |
22432893 | Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation. | 2012 Sep |
2 |
| 115 |
22483497 | Preemptive antiviral treatment for hepatitis C virus after living donor liver transplantation. | 2012 Apr |
2 |
| 116 |
22554247 | Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy. | 2012 Sep |
2 |
| 117 |
22577043 | Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection. | 2012 Nov |
1 |
| 118 |
22635082 | A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine. | 2012 |
1 |
| 119 |
22683884 | Longitudinal analysis of the 5'UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patients. | 2012 Aug |
1 |
| 120 |
22729189 | Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3. | 2012 May-Jun |
2 |
| 121 |
22783042 | Can zinc enhance response interferon therapy for patients with HCV-related liver disease? | 2012 Jul 7 |
2 |
| 122 |
22824093 | Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin? | 2012 Oct |
3 |
| 123 |
22863266 | Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3. | 2012 Sep |
1 |
| 124 |
22899224 | Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C. | 2012 Nov |
1 |
| 125 |
22985631 | Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin. | 2012 Nov |
1 |
| 126 |
23020144 | Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy. | 2012 Dec |
2 |
| 127 |
23109451 | IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. | 2012 Nov-Dec |
1 |
| 128 |
23258094 | Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy. | 2012 |
1 |
| 129 |
23359634 | Evolution of viral RNA in a Chinese patient to interferon/ribavirin therapy for hepatitis C. | 2012 Dec |
2 |
| 130 |
25755419 | The Distribution of Genotype and Allelic Frequency of IL28B Gene Polymorphism in Andhra Pradesh, India. | 2012 Jun |
1 |
| 131 |
29702891 | An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System. | 2012 Dec |
2 |
| 132 |
20438578 | Antiviral re-treatment of IFN-ribavirin non-responders for recurrent post-transplantation hepatitis C. | 2011 Jan-Feb |
1 |
| 133 |
20667172 | Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor? | 2011 Mar |
1 |
| 134 |
20822376 | Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2. | 2011 Jan |
1 |
| 135 |
20924369 | IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies. | 2011 Jan |
1 |
| 136 |
21111740 | Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. | 2011 Mar |
1 |
| 137 |
21143041 | Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients. | 2011 Feb |
3 |
| 138 |
21159314 | Genetic variation in BCL-2 and response to interferon in hepatitis C virus type 4 patients. | 2011 Mar 18 |
1 |
| 139 |
21254160 | Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. | 2011 Jan |
2 |
| 140 |
21269387 | Classification and characteristics of interferon-related diabetes mellitus in Japan. | 2011 Feb |
1 |
| 141 |
21320556 | Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. | 2011 Apr |
4 |
| 142 |
21439960 | High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial). | 2011 Jul |
1 |
| 143 |
21572662 | IFN-α-2a (Interferon) and ribavirin induced suicidal attempt in a patient of chronic HCV: A rare case report. | 2011 Apr |
1 |
| 144 |
21575275 | Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients. | 2011 May 17 |
2 |
| 145 |
21576995 | T helper type 1/T helper type 17-related cytokines in chronic hepatitis C patients before and after interferon and ribavirin therapy. | 2011 |
1 |
| 146 |
21603632 | Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C. | 2011 |
2 |
| 147 |
21734383 | Infections and the liver. | 2011 |
1 |
| 148 |
21748625 | De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case. | 2011 Jul |
1 |
| 149 |
21918436 | Host genetics. | 2011 Nov |
1 |
| 150 |
22114715 | Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV. | 2011 |
8 |